FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/06/019755 [Registered on: 19/06/2019] Trial Registered Prospectively
Last Modified On: 18/06/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To study the effect of vidang taila Nasya and Goghrut Nasya in Migraine 
Scientific Title of Study   RANDOMIZED CONTROLLED CLINICAL TRIAL TO STUDY THE EFFICACY OF VIDANG TAILA NASYA AND GOGHRITA NASYA IN THE MANAGEMENT OF ARDHAVBHEDAK 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Pallavi Pandurang Vyavahare 
Designation  MS Student 
Affiliation  Sumatibhai Shah Ayurved and Hospital 
Address  Department of Shalakyatantra Sumatibhai Shah Ayurved and Hospital hadapsar pune
Hadapsar Pune
Pune
MAHARASHTRA
411028
India 
Phone  7719921145  
Fax    
Email  drpallavivyavhare24@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Nilakshi S Pradhan 
Designation  Professor and HOD 
Affiliation  Sumatibhai Shah Ayurved and Hospital 
Address  Department of Shalakyatantra Sumatibhai Shah Ayurved and Hospital hadapsar pune
Hadapsar Pune
Pune
MAHARASHTRA
411028
India 
Phone  9423580963  
Fax    
Email  drnspradhan@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Pallavi Pandurang Vyavahare 
Designation  MS Student 
Affiliation  Sumatibhai Shah Ayurved and Hospital 
Address  Department of Shalakyatantra Sumatibhai Shah Ayurved and Hospital hadapsar pune
Hadapsar Pune
Pune
MAHARASHTRA
411028
India 
Phone  7719921145  
Fax    
Email  drpallavivyavhare24@gmail.com  
 
Source of Monetary or Material Support  
Sumatibhai shah Ayurved and Hospital Hadapsar Pune 
 
Primary Sponsor  
Name  Pallavi Pandurang Vyavahare 
Address  Sumatibhai shah Ayurved college and hospital Hadapsar Pune 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pallavi Vyavahare  Sane Guruji Arogya Kendra  Room no 8 and 9 Department of Shalakyatantra Sane guruji hospital Hadapsar Pune
Pune
MAHARASHTRA 
7719921145

drpallavivyavhare24@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G431||Migraine with aura,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  GOGHRITA   Nasya nasal drops 2 Drops in each nostril for 7 days 
Intervention  VIDANG TAILA   Nasya nasal drops 2 Drops in each nostril for 7 days 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patient suffering from symptoms of Ardhavbhedak
i.e. Ardha Manya, Bhru, Shankha, Karna, Akshi, Lalat Ativedanam and Shastra Arni Nibha and Bhrama

Patient between age group 20 to 60 yrs.

Patient of either gender.
 
 
ExclusionCriteria 
Details  Patients suffering from sinusitis systemic disorders like hypertension and dibetes

Secondary headache caused by meningitis tumor encephalitis and refractive errors

Pregnancy and lactation
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Alternation 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Subjective criteria ( by using Grades and Visual analogues Pain Scale)
Bhrama (giddiness)
Shatra Arni Nibha (Throbbing pain)
Unilateral severe pain affecting neck brow ear and orbital area forehead region

Objective criteria (by Gradation)

1 severity of headache
2 frequency of headache
3 duration of headache
4 Episode of Vomiting
4 Duration of Aura 
21 days 
 
Secondary Outcome  
Outcome  TimePoints 
Study the concept of Ardhavbhedak and Migraine in details
Study the Nasya Kriyakalpa and its uses indications contra indications complications  
21 days 
 
Target Sample Size   Total Sample Size="72"
Sample Size from India="72" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   25/06/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  
  1. Screening of patient of Ardhavbhedak will be done using a purposive sampling method. Followed by random sampling by lottery method, who meets the inclusion criteria, till the desired sample size is achieved.
  2.  72 Patient of Ardhavbhedak will be purposively selected in OPD/IPD basis irrespective of of gender, economic status, religion, occupation.
  3.  72 Patient will be allocated randomly into two groups-by Lottery methods.
  4. Group A (Trial Group): 36 patients will be treated with Vidang Taila Nasya for 7 days    Dose: 2 drops (1/2 ml)  Group B (Control Group):36 patients will be treated with Goghrita Nasya For 7 days Dose: 2 drops (1/2 ml).
  5. Criteria for assessment -

    subjective criteria will assess  will be assessed with help of  scoring pattern, Vas scale

    Objective criteria will be assess with the help of Grading Pattern 

 
Close